08-01-24 Shapiro Administration Invests Nearly $3 Million to Bring Adare Pharma Solutions’ Headquarters to Pennsylvania, Creating 115 New, Well-Paying Jobs in Philadelphia

Press Release Archives

The life sciences company is investing at least $16.8 million to relocate its headquarters to PA from New Jersey and upgrade its two current Philadelphia facilities, building on Pennsylvania’s reputation as a life sciences leader. FROM... Learn More

05-01-24 Adare Expands Global High Potency Handling & Packaging Capabilities

Press Release Archives

LAWRENCEVILLE, N.J., May 1, 2024 -- Adare Pharma Solutions, a global technology-driven CDMO specializing in oral dosage forms, today announced expansions of its high potency handling capabilities in the United States and Europe. In the... Learn More

03-12-24 Adare Pharma Solutions Expanding Oral Dose Capabilities In Europe

Press Release Archives

LAWRENCEVILLE, NJ, March 12, 2024 -- Adare Pharma Solutions, a global technology-driven CDMO focused on oral dosage forms, today announced it is further investing in its Pessano facility in Milan, Italy, with the addition of a high-shear... Learn More

03-05-24 Adare Pharma Solutions To Expand Packaging & Warehousing Capabilities In Europe

Press Release Archives

LAWRENCEVILLE, NJ, March 5, 2024 -- Adare Pharma Solutions, a global technology-driven CDMO focused on oral dosage forms, today announced that work has begun to add packaging capabilities and further warehousing capacity at its Pessano... Learn More

07-03-23 Adare Pharma Solutions announces divestiture of postbiotics pioneer Adare Biome to dsm-firmenich

Press Release Archives

PHILADELPHIA, Pennsylvania, July 3, 2023 — Adare Pharma Solutions, a global technology-driven CDMO focused on oral dosage forms, today announced the completion of its divestiture of its Adare Biome business unit, a pioneer in the... Learn More